Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?

Objective COVID-19 has been negatively impacted by a number of comorbidities. Aside from that, some conditions or treatments that cause immunosuppression can alter the course of the disease, leading to worse outcomes. The primary goal of this study is to compare the clinical presentation, laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Olgun Yıldızeli, Sehnaz, Vezir, Duygu, Cimsit, Canan, Kocakaya, Derya, Mercanci, Zeynep, Balcan, Baran, Ermerak, Onur, Ilgin, Can, Eryuksel, Emel, Karakurt, Sait
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186853/
https://www.ncbi.nlm.nih.gov/pubmed/37200662
http://dx.doi.org/10.7759/cureus.37633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186853/
https://www.ncbi.nlm.nih.gov/pubmed/37200662
http://dx.doi.org/10.7759/cureus.37633

Ejemplares similares